Company Search:
Advanced Search
Sponsored Links
Starpharma Holdings Limited - ADR Company Snapshot
Starpharma Holdings Limited operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Starpharma Holdings Limited with three other companies in this sector in UNITED STATES : Pharmaxis Ltd (2020 sales of $8.41 million of which 56% was Mannitol), Bioxyne Limited ($1.51 million ), and Applied Genetic Technologies Corp ($2.45 million of which 100% was Gene therapy).

Sales Analysis. During the year ended June of 2020, sales at Starpharma Holdings Limited were $4.77 million. This is an increase of 145.3% versus 2019, when the company's sales were $1.94 million.
  Stock Performance Chart for Starpharma Holdings Limited - ADR
  Stock Data: Recent Stock Performance:
  Current Price (11/30/2020): 9.52
(Figures in U.S. Dollars)
1 Week -4.6%   13 Weeks -3.0%  
4 Weeks -13.5%   52 Weeks 3.3%  
Starpharma Holdings Limited - ADR Key Data:
  Ticker: SPHRY Country: United States
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 4,768,971
(Year Ending Jan 2021).
Employees: 49
  Currency: U.S. Dollars Market Cap: 371,817,562
  Fiscal Yr Ends: June Shares Outstanding: 37,256,269
  Share Type: Common Closely Held Shares: 3,793,533
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.